364 related articles for article (PubMed ID: 12135981)
21. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
[TBL] [Abstract][Full Text] [Related]
22. [Secretion and role of autotaxin and lysophosphatidic acid in adipose tissue].
Saulnier-Blache JS
J Soc Biol; 2006; 200(1):77-81. PubMed ID: 17144165
[TBL] [Abstract][Full Text] [Related]
23. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.
Tokumura A; Majima E; Kariya Y; Tominaga K; Kogure K; Yasuda K; Fukuzawa K
J Biol Chem; 2002 Oct; 277(42):39436-42. PubMed ID: 12176993
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
Federico L; Pamuklar Z; Smyth SS; Morris AJ
Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
[TBL] [Abstract][Full Text] [Related]
25. Location, location, location: a crystal-clear view of autotaxin saturating LPA receptors.
Tabchy A; Tigyi G; Mills GB
Nat Struct Mol Biol; 2011 Feb; 18(2):117-8. PubMed ID: 21289650
[TBL] [Abstract][Full Text] [Related]
26. Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood.
Endo T; Kano K; Motoki R; Hama K; Okudaira S; Ishida M; Ogiso H; Tanaka M; Matsuki N; Taguchi R; Kanai M; Shibasaki M; Arai H; Aoki J
J Biochem; 2009 Aug; 146(2):283-93. PubMed ID: 19416959
[TBL] [Abstract][Full Text] [Related]
27. Measurement of autotaxin/lysophospholipase D activity.
Morris AJ; Smyth SS
Methods Enzymol; 2007; 434():89-104. PubMed ID: 17954243
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
Panupinthu N; Lee HY; Mills GB
Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
[TBL] [Abstract][Full Text] [Related]
29. Autotaxin and lysophospholipids in rheumatoid arthritis.
Bourgoin SG; Zhao C
Curr Opin Investig Drugs; 2010 May; 11(5):515-26. PubMed ID: 20419597
[TBL] [Abstract][Full Text] [Related]
30. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.
Ferry G; Tellier E; Try A; Grés S; Naime I; Simon MF; Rodriguez M; Boucher J; Tack I; Gesta S; Chomarat P; Dieu M; Raes M; Galizzi JP; Valet P; Boutin JA; Saulnier-Blache JS
J Biol Chem; 2003 May; 278(20):18162-9. PubMed ID: 12642576
[TBL] [Abstract][Full Text] [Related]
31. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.
Gijsbers R; Aoki J; Arai H; Bollen M
FEBS Lett; 2003 Mar; 538(1-3):60-4. PubMed ID: 12633853
[TBL] [Abstract][Full Text] [Related]
32. [Function and biological activities of the autotaxin-LPA axis].
Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
[TBL] [Abstract][Full Text] [Related]
33. Measurement of lysophospholipase D/autotaxin activity in human serum samples.
Nakamura K; Ohkawa R; Okubo S; Tozuka M; Okada M; Aoki S; Aoki J; Arai H; Ikeda H; Yatomi Y
Clin Biochem; 2007 Feb; 40(3-4):274-7. PubMed ID: 17222397
[TBL] [Abstract][Full Text] [Related]
34. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid, LPA: a bad boy becomes good.
Budnik LT
Reprod Biol Endocrinol; 2003 Apr; 1():37. PubMed ID: 12740030
[No Abstract] [Full Text] [Related]
36. Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation.
Harper K; Arsenault D; Boulay-Jean S; Lauzier A; Lucien F; Dubois CM
Cancer Res; 2010 Jun; 70(11):4634-43. PubMed ID: 20484039
[TBL] [Abstract][Full Text] [Related]
37. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
[TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
[TBL] [Abstract][Full Text] [Related]
39. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
40. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
Orosa B; García S; Conde C
Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]